BioPortUSA was recently certified as the first American Life Science Consultancy for the German State of Thuringia. “This is an amazing and humbling honor” stated Mark Lesselroth, CEO of BioPortUSA. With this certification companies wishing to work with BioPort can receive refunds from the RKW Thüringia up to 40% of the total project cost. [...]
Nexterus (https://www.nexterus.com) is a leading, full-service supply chain logistics provider with a rich history of helping small to medium sized companies stay ahead of the competition by employing best in class supply chain strategies. Founded in 1948, the company is entering the 4th generation of leadership.[...]
Mark Lesselroth, CEO of BioPortUSA was recently interviewed by the German Trade Publication medizin & technik on market entry into Canada.[...]
On Thursday, September 26th, BioPortUSA organized its first summit of subject matter experts. We had participants come from as far away as Louisville, KY, Baltimore, MD and Vermont. The main goal was to bring all of our team members together to introduce them to one another, and to examine how we as a collective ecosystem could help ease the market entry process for international life science companies into the United States.[...]
Fust Charles Chambers LLP, a leading accounting firm in Upstate New York,has joined the team at BioPortUSA to better service the needs of international life science companies looking to enter or expand their presence in the USA. [...]
The U.S. Consulate in Düsseldorf, Germany will play host to a VIP Event involving BioPortUSA and EY Life Sciences on November 17th. The presentation titled “Demystifing US Market Entry” will focus on what the international medical device community needs to take into consideration when contemplating market entry into the US healthcare market. The event is slated to take place one day before the start of MEDICA (https://www.medica-tradefair.com/), the worlds largest medical device show[...]
On June 4th, BioPortUSA CEO Mark Lesselroth had the honor to kick off the Global Innovation hub series at BIO in Philadelphia. As a result of this presentation, both Enterprise Singapore and Enterprise Spain reached out to BioPort to enquire how the company could be of service to life science organizations in those respective countries wishing to expand their operations into the United States. [...]
In May 2019, Mark Lesselroth, CEO of BioPortUSA and David Reed, Principal of Reed Business law, had an opportunity to join Jon Wilks our partner at UK HealthGateway to discuss the topic of Brexit and how it could impact US market entry for UK based medtech firms. [...]
Social Media
